Recombinant Ictalurid herpesvirus 1 Uncharacterized protein ORF28 (ORF28), partial

What is Ictalurid herpesvirus 1 and what is the significance of studying its ORF28 protein?

Ictalurid herpesvirus 1 (IcHV-1), also classified as Ictavirus ictaluridallo1, belongs to the genus Ictavirus within the Alloherpesviridae family and Herpesvirales order . This virus causes significant disease in channel catfish and blue catfish, resulting in substantial economic losses in catfish farms. The disease is endemic in the USA with reports of the virus in Honduras and Russia .

The study of ORF28 protein is significant because IcHV-1 contains a double-stranded DNA structure of approximately 134 kb that encodes 79 genes responsible for infection and viral spread . As an uncharacterized protein, understanding ORF28's structure and function could provide insights into viral replication mechanisms and potential therapeutic targets. Unlike some other viral proteins such as ORF59 (which has been identified as a structural protein potentially involved in virus entry), the specific function of ORF28 remains largely unknown, making it an important subject for research in understanding IcHV-1 pathogenesis .

How is recombinant ORF28 protein typically produced for research purposes?

Recombinant ORF28 protein for research applications is typically produced using yeast expression systems. According to available product specifications, the protein is expressed as a partial sequence with a purity of >85% as determined by SDS-PAGE analysis .

The methodological approach involves:

• Gene cloning: The ORF28 gene sequence is isolated from the IcHV-1 genome and cloned into an appropriate yeast expression vector.

• Transformation and expression: The recombinant vector is transformed into yeast cells which then express the protein, often with a tag to facilitate purification.

• Purification: The expressed protein undergoes purification procedures to achieve >85% purity as verified by SDS-PAGE .

• Quality control: The final product undergoes testing to confirm identity and functional integrity before being made available for research applications.

For experimental work, it's important to note that repeated freezing and thawing of the protein is not recommended, and working aliquots should be stored at 4°C for no more than one week to maintain protein integrity .

What are the optimal storage and handling conditions for recombinant ORF28 protein?

Optimal storage and handling of recombinant ORF28 protein requires specific conditions to maintain structural integrity and biological activity:

Storage conditions:

• Standard storage: -20°C for regular experimental timeframes

• Extended storage: -20°C to -80°C for long-term preservation

• Working aliquots: 4°C for up to one week

Handling recommendations:

• Centrifuge the vial briefly before opening to bring contents to the bottom

• Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (recommended default: 50%) for long-term storage

• Aliquot the reconstituted protein to minimize freeze-thaw cycles

• Avoid repeated freezing and thawing as this significantly reduces protein stability and activity

The shelf life of the protein varies depending on storage conditions: liquid form typically maintains integrity for approximately 6 months at -20°C/-80°C, while lyophilized form can be stored for up to 12 months at -20°C/-80°C . These parameters are critical for ensuring experimental reproducibility and reliable results when working with this uncharacterized viral protein.

What experimental approaches are recommended for characterizing the function of ORF28 protein in viral replication?

Multiple complementary experimental approaches are recommended for characterizing ORF28's function in viral replication:

Genetic manipulation approaches:

• Gene knockout/knockdown: CRISPR-Cas9 deletion or RNA interference targeting ORF28 in viral genome, followed by assessment of viral replication kinetics

• Complementation assays: Reintroduction of ORF28 into knockout strains to verify functional restoration

• Site-directed mutagenesis: Creating point mutations in conserved domains to identify critical functional residues

Protein interaction studies:

• Yeast two-hybrid screening to identify host or viral protein binding partners

• Co-immunoprecipitation followed by mass spectrometry to verify protein-protein interactions in native conditions

• Proximity labeling techniques (BioID or APEX) to capture transient interactions during viral replication

Localization and temporal expression studies:

• Immunofluorescence with anti-ORF28 antibodies at different time points post-infection

• Subcellular fractionation followed by Western blotting to determine compartmental localization

• Time-course analysis of ORF28 expression using RT-qPCR and Western blotting

Structural analysis:

• X-ray crystallography or cryo-EM to determine three-dimensional structure

• Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions

• Computational structure prediction validated by experimental data

These approaches should be integrated with studies of viral replication kinetics in the presence of ORF28 mutations or inhibition to establish causality between observed molecular phenomena and functional outcomes .

How can researchers design effective expression systems for studying ORF28 in different contexts?

Designing effective expression systems for ORF28 requires careful consideration of experimental objectives and biological context:

Prokaryotic expression systems:

• E. coli-based expression: Optimize codon usage for bacterial expression and consider fusion tags (His, GST, MBP) to enhance solubility and facilitate purification

• Cell-free protein synthesis: Useful for rapid production of potentially toxic proteins without cellular constraints

Eukaryotic expression systems:

• Yeast expression: Currently used for commercial production with demonstrated success (>85% purity)

• Insect cells (Baculovirus): Suitable for proteins requiring post-translational modifications

• Mammalian cell expression: For studies requiring mammalian-specific modifications or when studying interactions with mammalian proteins

Expression optimization strategies:

• Inducible promoters: Use tightly regulated promoters (T7-lac, GAL1, Tet-On/Off) to control expression timing and level

• Secretion signals: Add appropriate signal peptides for secreted expression when necessary

• Fusion partners: Consider fusion with fluorescent proteins (GFP, mCherry) for localization studies or split reporter systems for interaction studies

• Purification tags: Position tags (N- or C-terminal) based on structural predictions to minimize functional interference

Context-specific considerations:

• Native viral context: BAC-based recombineering for studying ORF28 in the complete viral genome

• Host cell context: Expression in relevant fish cell lines to maintain appropriate cellular environment

• Tissue-specific expression: For in vivo studies using fish models

When designing expressions systems, researchers should note that tag type and position may affect protein function, and should be determined during the manufacturing process based on predicted structure and function .

What are the challenges in studying protein-protein interactions involving ORF28?

Studying protein-protein interactions (PPIs) involving ORF28 presents several methodological challenges:

Technical challenges:

• Structural ambiguity: As an uncharacterized protein, the lack of structural information makes prediction of interaction domains difficult

• Expression difficulties: Viral proteins may be toxic or poorly expressed in heterologous systems

• Solubility issues: Membrane-associated viral proteins often have hydrophobic regions causing aggregation

• Post-translational modifications: Host-specific modifications may be critical for interactions but difficult to reproduce in expression systems

Experimental design challenges:

• Transient interactions: Many viral-host protein interactions are transient and context-dependent

• Temporal dynamics: Interactions may only occur during specific phases of viral replication

• Cellular localization: Compartmentalization can restrict access to potential interaction partners

• Low abundance: ORF28 may be expressed at low levels, making detection of interactions challenging

Methodological approaches to overcome these challenges:

Researchers should implement multiple complementary techniques (Y2H, co-IP, FRET, PLA) and validate interactions in the context of viral infection to overcome these challenges .

How is the expression of ORF28 regulated during viral infection?

The expression of ORF28 appears to be regulated through a complex bidirectional promoter system that controls both ORF28 and ORF29 genes. Based on studies of similar herpesvirus regulatory elements, the following regulatory mechanisms likely control ORF28 expression:

Transcriptional regulation:

• Bidirectional promoter element: The ORF28/29 intergenic region functions as a bidirectional promoter that can drive expression in both directions

• Transactivator dependence: Expression requires viral transactivator proteins for efficient transcription

• TATA element: A specific TATA element has been identified that directs transcription toward the ORF28 direction

• USF binding site: A consensus binding site for cellular transcription factor USF (Upstream Stimulatory Factor) is present in a 12-bp palindrome in the intergenic region and is essential for transactivation

• Sp1 involvement: The cellular transcription factor Sp1 appears to upmodulate USF-mediated activation

Temporal regulation:

• Gene class: Based on herpesvirus gene expression patterns, ORF28 is likely expressed as either an early (β) or late (γ) gene

• Replication-dependent expression: Late gene expression may be dependent on viral DNA replication

• Cell-type specific factors: Expression levels may vary based on host cell type and available cellular factors

Experimental evidence from similar systems:
Research on the Varicella-Zoster virus ORF28/29 regulatory element has shown that what was initially thought to be a single bidirectional promoter is actually "a fusion of two unidirectional promoters which overlap the consensus USF binding site and utilize different TATA elements" . This suggests that ORF28 and ORF29 can potentially be expressed either coordinately or independently based on the structure of their intergenic regulatory element, providing a sophisticated mechanism for temporal control during viral infection .

What tools and techniques are available for studying ORF28 promoter activity?

Several sophisticated tools and techniques can be employed to study ORF28 promoter activity in detail:

Reporter gene assays:

• Dual-reporter systems: Similar to the pRFL system described for ORF28/29 studies, where firefly luciferase represents one gene and Renilla luciferase represents the other, allowing simultaneous measurement of bidirectional promoter activity

• CAT reporter assays: Chloramphenicol acetyltransferase reporter constructs (e.g., p28CAT) to measure promoter strength in different conditions

• Fluorescent protein reporters: GFP/RFP constructs for real-time visualization of expression in living cells

Promoter mapping techniques:

• Truncation analysis: Creating a series of promoter fragments (e.g., short upstream, short downstream, minimal bidirectional, central fragment) to map functional elements

• Site-directed mutagenesis: Targeted mutation of specific elements like the USF binding site or TATA boxes to determine their contribution

• DNase I footprinting: To identify protein binding sites within the promoter region

Transcription start site identification:

• Primer extension analysis: Using labeled primers to identify the precise transcription start sites, as described in previous studies

• 5' RACE (Rapid Amplification of cDNA Ends): For mapping transcription start sites in different contexts

• RNA-Seq: For genome-wide transcriptome analysis including transcription start site identification

Protein-DNA interaction studies:

• Electrophoretic mobility shift assays (EMSA): To detect protein binding to specific promoter elements

• Chromatin immunoprecipitation (ChIP): To analyze protein-DNA interactions in the cellular context

• Magnetic bead recruitment assays: Using biotinylated promoter DNA coupled to streptavidin-conjugated magnetic beads to identify bound proteins, as described in previous research

These techniques can be applied under various conditions (different cell types, infection stages, presence/absence of viral transactivators) to develop a comprehensive understanding of ORF28 regulation during the viral life cycle .

What are the most effective protein purification strategies for recombinant ORF28?

Effective purification of recombinant ORF28 requires strategic planning based on protein properties and downstream applications:

Initial purification planning:

• Expression system selection: Yeast-based expression systems have proven successful for ORF28 production with yields of >85% purity

• Tag selection: Tag type should be determined based on protein characteristics and purification needs; common options include His-tag, GST, MBP, or FLAG

• Tag position: N- or C-terminal placement should be considered based on predicted functional domains

• Solubility assessment: Initial small-scale expression tests to determine solubility in different buffer conditions

Purification protocol development:

Protein-specific considerations:

• Concentration optimization: Reconstitute to 0.1-1.0 mg/mL in deionized sterile water as recommended

• Stabilization: Add glycerol to a final concentration of 5-50% (recommended default: 50%) for long-term storage

• Aliquoting strategy: Prepare small working aliquots to avoid repeated freeze-thaw cycles

• Quality assessment: Verify final purity by SDS-PAGE (target >85%) and confirm identity by mass spectrometry or Western blotting

Troubleshooting common challenges:

• Low solubility: Try detergent addition for membrane-associated regions

• Aggregation: Include reducing agents or optimize salt concentration

• Proteolytic degradation: Add protease inhibitors during purification

• Loss of activity: Test different buffer conditions to maintain native conformation

For research requiring high protein purity, a multi-step purification strategy is recommended, with each step optimized to maintain protein stability and function .

How can researchers design effective PCR-based detection methods for ORF28?

Designing effective PCR-based detection methods for ORF28 requires careful consideration of primer design, assay optimization, and validation:

Primer design strategies:

• Sequence analysis: Analyze the ORF28 sequence for unique regions suitable for specific amplification

• Conservation assessment: Compare ORF28 sequences across different IcHV-1 strains to identify conserved regions

• Specificity verification: Use BLAST analysis to ensure primers don't amplify host or other viral sequences

• Primer parameters: Design primers with:

  • Length: 18-30 nucleotides

  • GC content: 40-60%

  • Melting temperature (Tm): 55-65°C with <5°C difference between pairs

  • No secondary structures or primer-dimer formation

PCR protocol optimization:

• Master mix preparation: Include appropriate buffer, enzyme, dNTPs, and primers as described in protocols for similar viral targets

• Cycling conditions: Design a program with:

  • Initial denaturation (e.g., 95°C for 60 seconds)

  • 30-40 cycles of denaturation, annealing, and extension

  • Final extension (e.g., 72°C for 10 minutes)

• Annealing temperature optimization: Use gradient PCR to determine optimal annealing temperature

• Validation controls: Include positive controls (known IcHV-1 DNA), negative controls (water), and internal controls

Advanced detection methods:

• Quantitative real-time PCR (qPCR):

  • Design primers and probes specific to ORF28

  • Optimize reaction conditions for maximum sensitivity and specificity

  • Develop standard curves for quantification

• Multiplex PCR:

  • Design compatible primers for simultaneous detection of multiple viral genes

  • Include internal controls to verify sample quality and PCR efficiency

• Digital PCR:

  • For absolute quantification without standard curves

  • Useful for low copy number detection with high precision

Sensitivity and specificity validation:

• Analytical sensitivity: Determine limit of detection using serial dilutions

• Analytical specificity: Test against related viruses and host DNA

• Reproducibility assessment: Evaluate intra- and inter-assay coefficient of variation

• Field sample validation: Test with natural samples containing potential inhibitors

Similar approaches have been successful for other IcHV-1 genes, with primers designed on conserved regions showing good specificity and sensitivity for virus detection in various contexts .

What bioinformatic approaches are most valuable for analyzing ORF28 structure and function?

A comprehensive bioinformatic analysis of ORF28 can provide valuable insights into its potential structure and function through multiple computational approaches:

Sequence-based analyses:

• Homology detection:

  • PSI-BLAST and HHpred for remote homology detection

  • HMMER for profile-based searches against protein family databases

  • Delta-BLAST for enhanced sensitivity in detecting distant relationships

• Functional domain prediction:

  • InterProScan to identify conserved domains

  • SMART and Pfam searches for functional motifs

  • SignalP for signal peptide prediction

  • TMHMM for transmembrane domain identification

• Post-translational modification sites:

  • NetPhos for phosphorylation sites

  • NetNGlyc/NetOGlyc for glycosylation sites

  • SUMOplot for sumoylation sites

Structural predictions:

• Secondary structure prediction:

  • PSIPRED for α-helix and β-sheet prediction

  • JPred for consensus secondary structure

• Tertiary structure modeling:

  • AlphaFold2 for high-accuracy structure prediction

  • I-TASSER for template-based and ab initio modeling

  • SWISS-MODEL for homology modeling if templates are available

• Structural validation:

  • MolProbity for stereochemical quality assessment

  • PROCHECK for Ramachandran plot analysis

Evolutionary analyses:

• Multiple sequence alignment:

  • MUSCLE or MAFFT for aligning ORF28 across different viral strains

  • T-Coffee for incorporating structural information in alignments

• Phylogenetic analysis:

  • RAxML or IQ-TREE for maximum likelihood trees

  • MrBayes for Bayesian inference of evolutionary relationships

• Conservation analysis:

  • ConSurf for mapping conservation onto structural models

  • PAML for detecting sites under positive selection

Protein-protein interaction predictions:

• Interface prediction:

  • SPPIDER for identifying potential interaction sites

  • PredUs for structure-based interaction prediction

• Docking simulations:

  • HADDOCK for data-driven docking

  • ClusPro for protein-protein docking

Integration with experimental data:

• Mapping of epitopes for antibody production

• Identification of potential mutagenesis targets

• Prediction of critical residues for function

By integrating these bioinformatic approaches, researchers can generate testable hypotheses about ORF28's structure, function, and potential interactions, guiding experimental design and interpretation. This is particularly valuable for uncharacterized proteins like ORF28 where experimental data is limited .

How does ORF28 compare structurally and functionally to similar proteins in other herpesviruses?

Comparative analysis of ORF28 with similar proteins in other herpesviruses provides insights into its potential functions and evolutionary significance:

Structural comparisons:

• Sequence homology: ORF28 shares varying degrees of sequence identity with homologs in related viruses. For example, when comparing novel fish herpesviruses to IcHV-1, sequence identity between homologous ORFs at the amino acid level generally falls below 60% .

• Domain architecture: Computational predictions can identify conserved domains that may be shared with other herpesvirus proteins, though specific domain information for ORF28 is limited in the available literature.

• Predicted secondary structure elements: Alpha-helical and beta-sheet distributions can be compared across homologs to identify structurally conserved regions despite sequence divergence.

Functional comparisons:

• Promoter organization: The ORF28/29 promoter region in herpesviruses shows interesting conservation of regulatory elements. In Varicella-Zoster virus, this regulatory element consists of two unidirectional promoters that overlap a USF binding site, allowing for either coordinated or independent expression of ORF28 and ORF29 . This arrangement may be conserved in IcHV-1.

• Expression patterns: Temporal expression patterns during infection can provide clues about functional roles. Based on studies of other herpesviruses, ORF28 may fall into early (β) or late (γ) kinetic classes.

• Protein interaction networks: Comparing interaction partners across different herpesviruses can reveal conserved functional complexes.

Evolutionary considerations:

• Phylogenetic distribution: ORF28 homologs may be conserved across the Alloherpesviridae family, suggesting essential functions.

• Selection pressure analysis: Rates of synonymous vs. non-synonymous substitutions can identify regions under purifying or positive selection.

• Recombination events: Analysis of genomic organization around ORF28 in different viruses can reveal evolutionary history.

While specific comparative data for ORF28 is limited, this approach has proven valuable for other herpesvirus proteins. For example, studies of thymidine kinase genes in IcHV-1 and novel fish herpesviruses have shown amino acid identity levels of around 33%, providing insights into evolutionary relationships .

What insights from ORF59 studies can be applied to ORF28 research?

Research on ORF59, another protein in IcHV-1, provides valuable methodological insights and conceptual frameworks that can be applied to ORF28 studies:

Methodological insights:

• Recombinant protein production: Successful expression and purification strategies for ORF59 can inform approaches for ORF28. Both proteins have been produced as recombinant proteins, suggesting similar expression systems may be effective .

• Functional characterization techniques: Studies suggesting that recombinant ORF59 protein might inhibit CCV entry into host cells employed specific assays that could be adapted for ORF28 research .

• Structural analysis approaches: Methods used to characterize ORF59 as a glycoprotein can be applied to determine if ORF28 undergoes similar post-translational modifications.

Conceptual frameworks:

• Virus-host interaction models: ORF59's potential role in virus entry provides a framework for investigating whether ORF28 participates in similar processes or in different stages of the viral life cycle .

• Structural protein analysis: Research identifying ORF59 as one of 37 structural proteins in IcHV-1 suggests approaches for determining if ORF28 is a structural or non-structural protein .

• Inhibition mechanisms: If ORF59 inhibits viral entry, ORF28 might similarly affect other aspects of the viral life cycle, suggesting experimental designs to test for inhibitory or regulatory functions.

Research design translation:

• Cell entry assays: Adapting viral entry assays used for ORF59 studies to examine if ORF28 affects similar or different aspects of the viral replication cycle.

• Protein localization studies: Methods used to determine ORF59 localization in virions or infected cells can be applied to ORF28.

• Host protein interaction screenings: Techniques that identified ORF59 interaction partners can be used to discover ORF28's potential binding partners.

While the specific functions may differ, the methodological approaches and conceptual frameworks from ORF59 research provide valuable templates for designing comprehensive studies of the uncharacterized ORF28 protein .

What are the major unresolved questions regarding ORF28 function and regulation?

Despite available research on IcHV-1, several critical questions about ORF28 remain unanswered:

Functional characterization gaps:

• Biological role: The precise function of ORF28 in the viral life cycle remains unknown. Is it essential for viral replication or virulence?

• Protein classification: Is ORF28 a structural component of the virion or a regulatory/accessory protein?

• Host interactions: What host cell proteins, if any, does ORF28 interact with during infection?

• Post-translational modifications: Does ORF28 undergo modifications essential for its function?

• Enzymatic activity: Does ORF28 possess any catalytic activity or is it primarily a structural or scaffolding protein?

Regulatory mechanism questions:

• Temporal expression: When during infection is ORF28 expressed? Is it an immediate-early, early, or late gene?

• Bidirectional promoter dynamics: How does the ORF28/29 bidirectional promoter regulate expression of each gene in different contexts?

• Cell-type specificity: Does ORF28 expression vary in different host cell types?

• Regulation by viral factors: Which viral proteins regulate ORF28 expression?

• Stress response: How do environmental stressors affect ORF28 expression?

Structural biology questions:

• Three-dimensional structure: What is the tertiary structure of ORF28 and how does it relate to function?

• Functional domains: Which regions of ORF28 are critical for its activities?

• Oligomerization state: Does ORF28 function as a monomer or as part of a complex?

• Membrane association: Is ORF28 membrane-associated or soluble in the cytoplasm or nucleus?

Evolutionary considerations:

• Conservation: How conserved is ORF28 across different IcHV-1 strains and related herpesviruses?

• Selective pressure: Is ORF28 under purifying or diversifying selection?

• Homology: Do functional homologs exist in other virus families?

Addressing these questions will require integrative approaches combining molecular virology, structural biology, genomics, and cell biology techniques .

What emerging technologies might accelerate ORF28 research in the near future?

Several emerging technologies show promise for accelerating research on ORF28 and other uncharacterized viral proteins:

Advanced structural biology techniques:

• Cryo-electron microscopy (Cryo-EM): Near-atomic resolution structures of proteins without crystallization, particularly valuable for membrane-associated viral proteins

• Integrative structural biology: Combining multiple data sources (SAXS, NMR, crosslinking mass spectrometry) for comprehensive structural characterization

• AlphaFold2 and RoseTTAFold: AI-based structure prediction tools with unprecedented accuracy, useful for generating structural hypotheses about ORF28

High-throughput functional genomics:

• CRISPR-Cas9 screening: Genome-wide screens to identify host factors interacting with ORF28

• BioID and TurboID proximity labeling: Identification of transient protein interactions in living cells

• RNA-seq and Ribo-seq: Precise quantification of transcription and translation dynamics during infection

Single-cell technologies:

• Single-cell RNA-seq: Revealing cell-to-cell variability in response to viral infection

• Single-cell proteomics: Protein-level analysis of individual infected cells

• Live-cell imaging: Real-time visualization of ORF28 localization and dynamics during infection

Emerging protein engineering approaches:

• Nanobodies and intrabodies: For specific targeting and visualization of ORF28 in cellular contexts

• Optogenetic tools: Light-controlled activation or inhibition of ORF28 function

• Protein degradation technologies: Targeted degradation of ORF28 at specific time points using PROTAC or dTAG approaches

Advanced computational methods:

• Machine learning for sequence-function prediction: Improved prediction of protein function from sequence

• Molecular dynamics simulations: Insight into protein dynamics and conformational changes

• Network analysis tools: Integration of -omics data to place ORF28 in broader viral-host interaction networks

Innovative virus-host interaction technologies:

• Organoid infection models: Three-dimensional tissue models for studying viral pathogenesis

• Microfluidic devices: For studying single virus particle-cell interactions

• CRISPR activation/interference screens: For identifying host factors affecting ORF28 expression and function